Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on December 3, 2009. The report addresses corporate governance actions regarding the expiration of a poison pill provision and the subsequent elimination of associated preferred stock designations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial performance data.
Material Changes
- Expiration of Rights Agreement: All rights issued under the Amended and Restated Rights Agreement (dated August 27, 2001, amended September 29, 2003) expired on November 20, 2009, and are no longer outstanding.
- Elimination of Preferred Stock: On December 3, 2009, the company filed a Certificate of Elimination with the Delaware Secretary of State. This action eliminated the Certificate of Designations for Series A Preferred Stock, which were previously issuable upon the exercise of the expired rights.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the amendment of the Certificate of Incorporation.
Investor Verification Checklist
- Confirm the expiration date of the Rights Agreement (November 20, 2009).
- Verify the filing of the Certificate of Elimination with the Delaware Secretary of State on December 3, 2009.
- Ensure no Series A Preferred Stock remains outstanding following this elimination.